$KRMD News

Last published 1d ago

1d agoKRMDKORU Medical Systems, Inc. - PRESS RELEASE, DATED NOVEMBER 10, 2026Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
1d agoKRMDKORU Medical Systems Third Quarter 2026 Earnings Call - KORU MEDICAL SYSTEMS INCEarnings Call TranscriptsGreetings. Welcome to the Coral Medical System's third quarter 2026 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone sh
1d agoKRMDKORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDABusiness WireMAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 and Recent ...
3w agoKRMDKORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and
3mo agoKRMDCG 46TH ANNUAL GROWTH CONFERENCE - KORU MEDICAL SYSTEMS INCEarnings Call TranscriptsOkay, so good morning everyone. I'm Tom Adams, CFO of Koro Medical. Happy to be here today. I am going to show a couple slides just to give an overview of our company, what Koro does, Koro at a glance, strategic initiati
3mo agoKRMDKORU Medical Systems Second Quarter 2026 Earnings Call - KORU MEDICAL SYSTEMS INCEarnings Call TranscriptsGreetings and welcome to Coru Medical System's second quarter 2026 earnings conference call. At this time, all participants are on a listen-only mode. A question and answer session will follow the formal presentation. If
3mo agoKRMDKORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and
3mo agoKRMDKORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth ConferenceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and
3mo agoKRMDKORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and
5mo agoKRMDKORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society CongressBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced
6mo agoKRMDKORU Medical Systems Announces First Quarter 2026 ResultsBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
6mo agoKRMDKORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
8mo agoKRMDKORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe CompatibilityBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
8mo agoKRMDKORU Medical Systems Announces CEO TransitionBusiness WireLinda Tharby to Retire after Five Years of Transformational Leadership; Adam Kalbermatten Appointed CEO, effective July 1, 2026 KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading
8mo agoKRMDKORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
8mo agoKRMDKORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
9mo agoKRMDKORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion SystemBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
10mo agoKRMDKORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology BiologicBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
11mo agoKRMDKORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology OfficerBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative and patient-centric large volume
11mo agoKRMDKORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced
12mo agoKRMDKORU Medical Systems to Participate in Upcoming Investor ConferencesBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume
12mo agoKRMDKORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion SystemsBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use
1y agoKRMDKORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDCirtec Medical Announces Appointment of New Chief Executive OfficerGlobeNewswireBROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to
1y agoKRMDKORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoKRMDKORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth ConferenceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial OfficerBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and
1y agoKRMDKORU Medical Systems to Join Russell 3000® and Russell 2000® IndexesBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025Business WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion SystemBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
1y agoKRMDKORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in NephrologyBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume
1y agoKRMDKORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth QuarterBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume
1y agoKRMDKORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare ConferenceBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume
1y agoKRMDKORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoKRMDKORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
2y agoKRMDKORU Medical Systems to Participate in Upcoming Investor ConferencesBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large
2y agoKRMDKORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology InfusionBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric
2y agoKRMDKORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024Business WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume
2y agoKRMDKORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth ConferenceBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume
2y agoKRMDKORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoKRMDKORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 GuidanceBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
2y agoKRMDKORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth ConferenceBusiness WireKORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume
2y agoKRMDKORU Medical Systems, Inc Announces Leadership Changes to Support Growth AgendaBusiness WireKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and